{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:55:16Z","timestamp":1790668516174,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-026-01290-3","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:50:14Z","timestamp":1788555014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Betting on Biology: Rethinking Probability as the Currency of Risk in Biotechnology Portfolios"],"prefix":"10.1208","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3127-9732","authenticated-orcid":false,"given":"Rajesh","family":"Krishna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"1290_CR1","unstructured":"U.S. Food and Drug Administration. 21st Century Cures Act implementation plan and regulatory modernization initiatives. N Engl J Med. 2017;377(12):1111\u20131115."},{"key":"1290_CR2","unstructured":"European Medicines Agency. Adaptive pathways and PRIME: enhancing early dialogue and accelerated assessment. Clin Pharmacol Ther. 2016;100(3):234\u2013238."},{"issue":"6","key":"1290_CR3","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","volume":"90","author":"DG Maloney","year":"1997","unstructured":"Maloney DG, Grillo-L\u00f3pez AJ, White CA, et al. IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin\u2019s lymphoma. Blood. 1997;90(6):2188\u201395.","journal-title":"Blood"},{"issue":"2","key":"1290_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/d41573-019-00014-x","volume":"18","author":"A Mullard","year":"2018","unstructured":"Mullard A. 2018 FDA drug approvals. Nat Rev Drug Discov. 2018;18(2):85\u20139.","journal-title":"Nat Rev Drug Discov"},{"key":"1290_CR5","doi-asserted-by":"crossref","unstructured":"Pfizer Inc. Development and licensure of a BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383(27):2603\u20132615.","DOI":"10.1056\/NEJMoa2034577"},{"issue":"5","key":"1290_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMoa1709866","volume":"378","author":"AG Novartis","year":"2018","unstructured":"Novartis AG. CAR-T cell therapy for B-cell acute lymphoblastic leukemia (tisagenlecleucel). N Engl J Med. 2018;378(5):439\u201348.","journal-title":"N Engl J Med"},{"issue":"7539","key":"1290_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature14177","volume":"518","author":"GR Abecasis","year":"2014","unstructured":"Abecasis GR, Auer PL, et al. Exome sequencing identifies loss-of-function variants in APOC3 associated with reduced risk of coronary heart disease. Nature. 2014;518(7539):197\u2013206.","journal-title":"Nature"},{"issue":"12","key":"1290_CR8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1056\/NEJMoa054013","volume":"354","author":"JC Cohen","year":"2006","unstructured":"Cohen JC, Boerwinkle E, Mosley TH, Hobbs HH. Sequence variations in PCSK9 and low LDL cholesterol. N Engl J Med. 2006;354(12):1264\u201372.","journal-title":"N Engl J Med"},{"issue":"5","key":"1290_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMoa1709866","volume":"378","author":"SL Maude","year":"2018","unstructured":"Maude SL, Laetsch TW, Buechner J, et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N Engl J Med. 2018;378(5):439\u201348.","journal-title":"N Engl J Med"},{"issue":"5","key":"1290_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMra1706910","volume":"381","author":"KA High","year":"2019","unstructured":"High KA, Roncarolo MG. Gene therapy. N Engl J Med. 2019;381(5):455\u201364.","journal-title":"N Engl J Med"},{"issue":"3","key":"1290_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2031054","volume":"384","author":"H Frangoul","year":"2021","unstructured":"Frangoul H, Altshuler D, Cappellini MD, et al. CRISPR\u2013Cas9 gene editing for sickle cell disease and \u03b2-thalassemia. N Engl J Med. 2021;384(3):252\u201360.","journal-title":"N Engl J Med"},{"issue":"27","key":"1290_CR12","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315.","journal-title":"N Engl J Med"},{"issue":"5","key":"1290_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403\u201316.","journal-title":"N Engl J Med"},{"issue":"8","key":"1290_CR14","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s40265-019-01136-7","volume":"79","author":"LJ Scott","year":"2019","unstructured":"Scott LJ. Risankizumab: a review in moderate to severe plaque psoriasis. Drugs. 2019;79(8):893\u2013900.","journal-title":"Drugs"},{"issue":"7","key":"1290_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrd.2016.136","volume":"15","author":"A Mullard","year":"2016","unstructured":"Mullard A. Parsing clinical success rates. Nat Rev Drug Discov. 2016;15(7):447.","journal-title":"Nat Rev Drug Discov"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01290-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-026-01290-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01290-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:02:48Z","timestamp":1790665368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-026-01290-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1290"],"URL":"https:\/\/doi.org\/10.1208\/s12248-026-01290-3","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Author declares none.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"130"}}